Clinical Trial Update: PV-10 Chemoablation of Recurrent Breast Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating PV-10 chemoablation for recurrent breast carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PV-10 (Rose Bengal disodium)

Snippet

Sponsor: Provectus Pharmaceuticals | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED